Table 2: Meta-analyses of RCTs of dietary and nutrient interventions in the management or prevention of gestational hypertension | ||||
Interventions | Outcome | Total sample size | No. of RCTs | OR (and 95% CI) |
Dietary advice v. no advice33 | Preeclampsia | 136 | 1 | 0.86 (0.33-2.22) |
Isoenergetic balanced protein supplementation v. no supplementation34 | Pre-eclampsia | 782 | 1 | 1.00 (0.55-1.88) |
Balanced protein and energy supplementation v. no supplementation35 | Pre-eclampsia | 516 | 3 | 1.25 (0.72-2.17) |
Restriction of energy intake v. no restriction in overweight women36 | Pre-eclampsia | 284 | 2 | 1.15 (0.55-2.40) |
Low v. high salt intake37 | Hypertension | 36 | 1 | 1.78 (0.28-11.52) |
Proteinuria | 36 | 1 | 1.12 (0.07-18.75) | |
Prophylactic magnesium supplementation v. placebo38,39 | Pre-eclampsia | 942 | 2 | 0.94 (0.61-1.44) |
Magnesium supplementation in women with established hypertension40 | Use of antihypertensive drugs | 58 | 1 | 1.54 (0.55-4.28) |
Prophylactic calcium supplementation v. placebo41 | Hypertension | 1729 | 6 | 0.44 (0.33-0.59)* |
Proteinuric pre-eclampsia | 1729 | 6 | 0.34 (0.22-0.54)* | |
Calcium supplementation v. placebo in women with established preeclampsia42 | Severe pre-eclampsia | 75 | 1 | 1.05 (0.43-2.59) |
Zinc supplementation v. no supplementation43 | Hypertension | 656 | 2 | 0.76 (0.37-1.60) |
Iron supplementation v. no supplementation44 | Proteinuric hypertension | 203 | 3 | 0.74 (0.25-2.20) |
Folate supplementation v. no supplementation45 | Proteinuric hypertension | 936 | 3 | 1.28 (0.86-1.90) |
*Statistically significant. |